Conquering Diseases

A Study Looking At Whether Adding A New Drug To Existing Treatments Can Cause Improve A Specific Form Of Cancer


Seeking men and women over 18 years of age who have a specific form of cancer called Follicular Lymphoma to determine if adding a new drug to existing treatments can lead to improvements in individuals where their cancer has come back or did not get better compared to existing treatments alone


We are studying the effects of a new investigational drug called Epcoritamab in individuals with a specific form of lymphoma, called Follicular Lymphoma, that has come back or has not responded to existing treatments. This drug would be added to existing treatments.

What we're hoping for

To evaluate whether individuals with Follicular Lymphoma where their cancer has come back or not improved to existing treatments respond better to an investigational new drug called Epcoritamab being added to existing treatments.

Additional Information Identifier: NCT05409066

 Principal Investigator

Andrew  Gillis-Smith, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office



UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655